Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05167786 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.
MinorPrimary completion date: Aug 25, 2026 to Jul 31, 2026
Study completion date: Aug 25, 2027 to Jul 31, 2027
v7
MinorRe-verified, no change to tracked fieldsv6
MinorInterventions: Conventional gait training (Device), Exploratory Phase - Optimization of Gait Training and Spinal Stimulation (Other), Noninvasive spinal… to Conventional gait training (Device), Exploratory Phase - Optimization of Gait Training and Spinal Stimulation (Other), Noninvasive spinal…
Study arms: 6 to 4
v5
MinorRe-verified, no change to tracked fieldsv4
MinorInterventions: Conventional gait training (Device), Noninvasive spinal stimulation (Device), Noninvasive spinal stimulation with gait training (Device)… to Conventional gait training (Device), Exploratory Phase - Optimization of Gait Training and Spinal Stimulation (Other), Noninvasive spinal…
Eligibility criteria expanded, about 28 words
Secondary endpoints: details revised at 2 of 2 entries
Study description expanded, about 4 words
v3
NotableTrial status: Not Yet Recruiting to Recruitingv2Show 5 more changesShow less
Enrollment target: 75 to 115
Start date changed from estimate of Feb 1, 2022 to Mar 1, 2022
Study description expanded, about 25 words
Site details revised
Study arms: 4 to 6
MinorStudy First Submitted
Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study has two interventional components, the first is a cross-over design and the second is a randomized control trial. Both will evaluate the effectiveness of transcutaneous (non-invasive) spinal cord stimulation on gait and balance function for individuals with hemiplegia due to stroke.